Difference between effect of Intraoperative goal-directed fluid therapy versus conventional fluid therapy in major gastrointestinal cancer surgery and postoperative pulmonary complication; a prospective randomized controlled trial
Phase 4
- Conditions
- Health Condition 1: C15-C26- Malignant neoplasms of digestive organsHealth Condition 2: C15-C26- Malignant neoplasms of digestive organsHealth Condition 3: O- Medical and SurgicalHealth Condition 4: O- Medical and SurgicalHealth Condition 5: O- Medical and Surgical
- Registration Number
- CTRI/2023/08/056510
- Lead Sponsor
- Bhagwan mahaveer cancer hospital jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients (18 years or older) posted for Elective Open or Laparoscopic
ASA grade 1-2 patients
Patients posted for gastro-intestinal cancer surgeries
Exclusion Criteria
Patients posted for liver resection and esophageal surgery
Expected massive blood loss >500ml
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post operative Pulmonary complicationTimepoint: Post operative Pulmonary complication during intraoperative, post operative at 24hr, 48hrs and within 30 days post operatively
- Secondary Outcome Measures
Name Time Method To assess 30 days perioperative morbidity & mortality along with length of hospital stay <br/ ><br>Timepoint: 0, 24 hr, 48hr
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie goal-directed fluid therapy's impact on postoperative pulmonary complications in gastrointestinal cancer surgery?
How does intraoperative goal-directed fluid therapy compare to conventional fluid therapy in reducing postoperative pulmonary complications in major gastrointestinal cancer surgery?
Are there specific biomarkers that predict response to goal-directed fluid therapy in patients undergoing major gastrointestinal cancer surgery?
What are the known adverse events associated with intraoperative goal-directed fluid therapy in gastrointestinal cancer surgery and how are they managed?
What are the potential combination approaches or alternative therapies that could enhance the outcomes of goal-directed fluid therapy in gastrointestinal cancer surgery?